ID

26375

Description

Study Part: Investigator’s Statement. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Mots-clés

  1. 16/10/2017 16/10/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

16 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Investigator’s Statement Ropinirole Parkinson Disease 101468/165

Investigator’s Statement

INVESTIGATOR’S STATEMENT
Description

INVESTIGATOR’S STATEMENT

Alias
UMLS CUI-1
C1710187
UMLS CUI-2
C2826892
Patient Number
Description

Patient Number

Type de données

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Description

Centre Number

Type de données

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Check that all appropriate pages are signed (thus indicating completion) and dated
Description

completion status

Type de données

boolean

Alias
UMLS CUI [1]
C0805732
Check that laboratory results are included
Description

Check that laboratory results are included

Type de données

boolean

Alias
UMLS CUI [1]
C1254595
I certify that the observations and findings are recorded correctly and completely in this CRF.
Description

consent

Type de données

boolean

Alias
UMLS CUI [1]
C1511481
Investigator:
Description

Investigator

Type de données

text

Alias
UMLS CUI [1]
C2826892
Date
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008

Similar models

Investigator’s Statement

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
INVESTIGATOR’S STATEMENT
C1710187 (UMLS CUI-1)
C2826892 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
completion status
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C0805732 (UMLS CUI [1])
Check that laboratory results are included
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
consent
Item
I certify that the observations and findings are recorded correctly and completely in this CRF.
boolean
C1511481 (UMLS CUI [1])
Investigator
Item
Investigator:
text
C2826892 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial